Delivery Order SPE2DB22D7065-SPE2DB25FH3EQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $8,001.71. This is a firm fixed price, non-competitive delivery order executed under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30 count) valued at $9,934.75 under a firm fixed price contract type. This is a non-set-aside award issued on July 14, 2025, with a completion date of July 15, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count packages) under a firm fixed-price contract valued at $13,195.78. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-set-aside competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the...
- The Defense Logistics Agency awarded a $1,503.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This non-set-aside competitive award will be performed in Conshohocken, Pennsylvania, with completion expected by June 3, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $11,629.29 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This firm fixed-price contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 8, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) valued at $5,753.05 under a firm fixed-price contract. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a non-set-aside competitive award, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls...
- The Defense Logistics Agency awarded a $5,629.86 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters location of the prime contractor. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units, with a contract ceiling value of $4,745.90. This is a firm fixed price delivery order with no set-aside designation, awarded through open competition to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,882.56 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded and completed on August 8, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count package, with a contract ceiling value of $2,747.70. This delivery order represents a firm fixed-price, non-set-aside competitive award with an ultimate completion date of May 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery...
- SPE2DB22D7065Indefinite Delivery Contract
- SPE2DB22D7065-SPE2DB25FH3EQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract valued at $3,343.37. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a competitively awarded, non-set-aside order with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive pharmaceutical and medical supply portfolio. The company's SPE2DX prime contract vehicle provides global pharmaceutical support to military healthcare programs, enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This particular delivery order for ondansetron, an anti-nausea medication commonly used in medical settings, exemplifies the company's role in supporting Defense Health Agency operations and broader military healthcare requirements through flexible and streamlined procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 7/18/25 |